The Effect of Donepezil on Glycemic Control in Type II Diabetics
NCT04507438
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
7
Enrollment
OTHER
Sponsor class
Stopped
Lack of enrollment
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
Donepezil 5-10 Mg Oral Tablet
DRUG:
Placebo Oral Tablet
Sponsor
University of Maryland, Baltimore